ARTICLE | Company News
Cancer Genetics sales and marketing update
April 14, 2014 7:00 AM UTC
Cancer Genetics launched its CALR mutation analysis test to help diagnose patients with essential thrombocythemia and primary myelofibrosis. The company offers the PCR-based test, which detects mutat...